To assess the validity of adult attention-deficit/hyperactivity disorder (ADHD), we reviewed
clinical, family, psychopharmacologic, neurobiological, and outcome studies. We found …

OBJECTIVE: While it is increasingly recognized that attention deficit hyperactivity disorder
(ADHD) persists into adulthood, there is no consensus on diagnostic criteria for adult ADHD …

BACKGROUND: The few controlled studies of methylphenidate (MPH) in adults with
attention deficit/hyperactivity disorder (ADHD) have reported equivocal results. A previous …

BACKGROUND: Before 1980, attention-deficit/hyperactivity disorder (ADHD) was called
minimal brain dysfunction and included emotional symptoms now listed as “associated …

Thoroughly updated for its Sixth Edition, Handbook of Psychiatric Drug Therapy is one of the
most popular guides to the essential facts about all drugs used to treat anxiety, depression …

Attention-deficit/hyperactivity disorder (ADHD) is an established diagnosis in children,
associated with a large body of evidence on the benefits of treatment. Adolescents with …

In this 12-week double-blind placebo-controlled trial of methylphenidate (MTP) versus
placebo in 48 cocaine-dependent attention-deficit/hyperactivity disorder (ADHD) adults, the …

There is a substantial body of literature documenting the efficacy of multiple unrelated
pharmacological agents in attention-deficit hyperactivity disorder (ADHD) individuals …

Background We report on a controlled trial of a mixed amphetamine salts compound
(Adderall, dextroamphetamine sulfate, dextro-, levoamphetamine sulfate …

OBJECTIVE: Despite the increasing recognition of attention deficit hyperactivity disorder
(ADHD) in adults, there is a paucity of controlled pharmacological trials demonstrating the …